IBEX Ltd increased fiscal-year Revenue 15.4% to $644.076 million and reported Net Income of $46.331 million for the year ended June 30, 2026. The results matter to investors because growth extended across five operating verticals, led by HealthTech, while Telecommunications declined and the company authorized $20 million in share repurchases.

Key Highlights

  • HealthTech revenue increased $31.7 million, or 38.5%, during the fiscal year.
  • IBEX authorized $20 million in share repurchases on May 11, 2026.
  • Telecommunications revenue decreased $13.6 million, or 18.7%, over the same period.

IBEX Ltd (NASDAQ: IBEX) increased revenue 15.4% to $644.076 million for the fiscal year ended June 30, 2026, while net income reached $46.331 million. Growth came from the digital Acquisition Business and gains across HealthTech, Retail & E-commerce, Travel, Transportation & Logistics, Technology and Other. Telecommunications partly offset those increases. The results mark a year of higher revenue and profit for IBEX. The company also continued share repurchases during the period and set a $20 million authorization for the following twelve months.

Fiscal Revenue And Profit

IBEX generated $644.076 million of revenue in the fiscal year ended June 30, 2026, up $85.803 million, or 15.4%, from the prior year. Net income was $46.331 million, compared with $36.864 million in the prior year, an increase of $9.467 million, or 25.7%. Income from operations reached $54.964 million, compared with $46.611 million in the prior year. Income before income taxes was $54.294 million, compared with $45.932 million, while the provision for income tax expense was $7.963 million. Basic net income per share was $3.45 and diluted net income per share was $3.13. Basic weighted-average common shares outstanding were 13,414,000, while diluted weighted-average common shares outstanding were 14,808,000. Total comprehensive income was $41.180 million. Other comprehensive loss totaled $5.151 million, including a foreign currency translation adjustment of $3.140 million, an unrealized loss on Cash Flow hedging instruments of $2.535 million and an actuarial loss on the defined benefit plan of $524,000. HealthTech revenue increased $31.7 million, or 38.5%, compared with the prior year. Retail & E-commerce added $20.5 million, or 14.1%, while Travel, Transportation & Logistics increased $13.3 million, or 17.2%. Technology revenue rose $11.1 million, or 25.6%, and Other increased $21.5 million, or 28.9%. Telecommunications moved in the opposite direction, declining $13.6 million, or 18.7%. The company attributed the overall increase primarily to growth in its digital acquisition business. The gains in five verticals were partially offset by the Telecommunications decrease. HealthTech represented 17.7% of total revenue, compared with 14.7% in the prior year. Technology accounted for 8.4%, compared with 7.8%, while Other represented 14.9%, compared with 13.3%. Retail & E-commerce accounted for 25.7% of revenue, and Travel, Transportation & Logistics represented 14.1%, with both percentages remaining consistent with the prior year. Telecommunications accounted for 9.2%, compared with 13.1%. Revenue from clients in the United States was $623.050 million, while revenue from other countries was $21.026 million. Services delivered from onshore locations generated $169.631 million, offshore locations generated $327.272 million and nearshore locations generated $147.173 million. Services transferred over time contributed $572.919 million of revenue. Services transferred at a point in time contributed $71.157 million.

Repurchases And Capital Allocation

IBEX’s board authorized $20 million in share repurchases on May 11, 2026, covering the next twelve months. The authorization does not require the company to purchase a particular amount of common shares. The company repurchased 452,758 common shares during the fiscal year for a total of $14.4 million. Those purchases were funded with existing cash balances. The purchases were made through publicly announced programs. April purchases totaled 48,300 shares at an average price of $28.17 per share. May purchases totaled 46,000 shares at $30.89 per share, while June purchases totaled 48,300 shares at $30.47 per share. The board may adjust, suspend or discontinue the program.

Currency And Operating Risks

IBEX identifies numerous risks and uncertainties affecting forward-looking statements, including risks connected with its industry, future performance, Liquidity and capital resources. Actual results may differ materially from those statements. Foreign currency movements are another identified risk. IBEX hedges part of its Philippine operating costs against foreign exchange fluctuations. The company states that its hedging strategy can protect against short-term currency risks, while an overall strengthening of the Philippine peso would adversely affect margins over the long term. Borrowings under the U.S. Credit Facility carry interest at term SOFR plus 2% or alternate Base Rate plus 1%, while borrowings under the UAE Loan Facility carry interest at three-month term SOFR plus 2%.